| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.753 | 35.416 | 38.736 | 47.140 | 57.259 | 58.496 | 60.553 | 73.480 | 91.888 | 106.723 |
| Total Income - EUR | 26.753 | 35.417 | 38.736 | 47.141 | 57.259 | 58.510 | 61.565 | 73.481 | 92.600 | 107.241 |
| Total Expenses - EUR | 18.762 | 22.390 | 25.280 | 26.080 | 34.577 | 33.780 | 35.188 | 35.284 | 42.511 | 54.516 |
| Gross Profit/Loss - EUR | 7.991 | 13.027 | 13.456 | 21.061 | 22.682 | 24.730 | 26.376 | 38.198 | 50.090 | 52.726 |
| Net Profit/Loss - EUR | 7.188 | 12.673 | 13.069 | 20.589 | 22.110 | 24.145 | 25.771 | 37.477 | 49.182 | 49.896 |
| Employees | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
Check the financial reports for the company - Sandidi Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 2.450 | 2.003 | 1.573 | 1.232 | 1.557 | 1.183 | 418 |
| Current Assets | 8.899 | 19.830 | 26.108 | 26.765 | 44.816 | 59.407 | 45.078 | 50.725 | 52.780 | 63.965 |
| Inventories | 0 | 0 | 0 | 0 | 953 | 39 | 679 | 0 | 2.430 | 987 |
| Receivables | 6.093 | 6.834 | 6.613 | 7.986 | 8.836 | 8.686 | 12.965 | 14.852 | 23.761 | 8.580 |
| Cash | 2.806 | 12.997 | 19.495 | 18.779 | 35.027 | 50.682 | 31.434 | 35.873 | 26.590 | 54.397 |
| Shareholders Funds | 7.233 | 13.152 | 20.085 | 25.328 | 42.311 | 54.490 | 41.755 | 45.701 | 49.223 | 60.145 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.666 | 6.679 | 6.023 | 3.886 | 4.507 | 6.490 | 4.555 | 6.581 | 4.740 | 4.238 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sandidi Med S.r.l.